groups
Population | Subjects, N | PST sessions, N | Therapists | Treatment fidelity | Primary outcome | Summary of results | Rovner et al., 2013 [ ] | PST vs. ST | Patients of retina clinics | 241 | 6 in 12 wk | Bachelor's- or master's-level graduates of social sciences | 30% of audiotaped sessions; supervision | Targeted vision function | PST was not superior to ST in improving vision function in patients with age-related macular degeneration; PST improved vision-related quality of life. |
Choi et al., 2013 [ ] | Tele-PST vs. in-person PST vs. TS | Homebound older adults from aging-network agencies | 121 | 6 weekly | Licensed master's-level social workers | 2 sessions of 20% of subjects | Acceptance of PST; depression | Both PST groups showed acceptance of PST. Tele-PST and in-person PST depression scores were significantly lower at 12 wk than scores of participants in the TS condition; gains were maintained at 24 wk. |
Chan et al., 2012 [ ] | EN+PST vs. EN vs. PST vs. control | Community-dwelling older adults | 117 | 6 in 3 mo | Trained case managers | NR | Frailty (CHS-PCF) | No significant differences in the measures of primary outcome between participants who received PST and those who did not |
Demiris et al., 2012 [ ] | Face-to-Face PST vs. PST via videophone | Family hospice caregivers from urban hospice agencies | 126 | 3 in 20 d | Registered nurses and master's-level social workers | 10% of sessions were reviewed | Caregiver quality of life/anxiety | No significant differences between the two groups in improvement of quality of life and reduction of anxiety |
Alexopoulos et al., 2011 [ ]; Areán et al, 2010 [ ] | PST vs. ST | Clinician referrals and responders to advertisement | 221 | 12 weekly | Doctoral-level clinical psychologists and licensed social workers | 20% of sessions reviewed; supervision | Depression/disability | PST participants had significantly greater reduction in depression and disability than ST participants at 12 wk. |
Kiosses et al., 2010 [ ] | PATH vs. ST-CI | Responders to advertisement and referrals from collaborative agencies | 30 | 12 weekly | Doctoral-level clinical psychologists and licensed social workers | Supervision | Depression/disability | Participants in PATH (PST + environmental adaptations + caregiver involvement) had significantly greater reduction in depression and disability than ST participants over 12 wk |
Gellis et al., 2010 [ ] | PST-HC vs. UC+E | Home-care agency patients | 38 | 6 in 6 wk | Master's-level social workers | Supervision | Depression/anxiety | Participants in PST-HC had significantly greater reduction in depression but not anxiety than UC+E participants. |
Lam et al., 2009 [ ] | PST-PC vs. group-video PBO | Outpatient clinics | 291 | 3 in 6 wk | Primary care doctors | Random sample of 1st session of 3 subjects per doctor | Quality of life | Mixed-effects model analysis did not show significant differences in outcome measure between the two groups. Participants receiving PST-PC had significant improvement in role-emotional and mental component summary (SF-36 Health-Related Quality of Life) at the end of treatment. The PBO group showed no such improvement. |
Robinson et al., 2008 [ ]; Mikami et al., 2013 [ ] | Escitalopram vs. PBO vs. PST | Stroke patients | 176 | 6 in 1st 12 wk; 6 booster sessions in following 9 mo | NR | Reviews of audiotaped or videotaped sessions; supervision | Onset of MDD or minor depression | Depression [ ]: Among stroke patients, PST participants were less likely to develop a major or minor depressive episode than the PBO group. This difference became nonsignificant in a more conservative analysis, which assumed that baseline patients who did not continue the study would have developed depression. Apathy [ ]: Escitalopram or PST was significantly more effective in preventing new onset of apathy following stroke compared with PBO. |
Gellis et al., 2007 [ ] | PST-HC vs. UC | Home-care agency patients | 40 | 6 in 8 wk | Master's-level social workers | Supervision | Depression/quality of life | Participants in PST-HC had greater reduction in depression and greater improvement in quality of life over the course of 6 mo. |
Rovner et al., 2007 [ ]; Rovner and Casten, 2008 [ ] (prevention study) | PST vs. UC | Patients of retinovitreous clinics | 206 | 6 in 8 wk | Nurses and master's-level counselor | 1/3 of sessions reviewed | Onset of MDD | PST-treated participants had significantly lower 2-mo incidence rates than UC participants. Participants in PST were less likely than UC participants to suffer persistent depression at 6 mo, even though most earlier benefits were diminished. |
Downe-Wamboldt et al., 2007 [ ] | Telephone PST+UC vs. UC | Patients of academic center cancer clinic | 149 | Sessions varied in 3 mo based on negotiation with patient | Nurse counselor | Examinationof nurses' written records | Coping/depression/p sychosocial adjustment | Participants in PST demonstrated greater improvement in certain coping areas at 8 mo (5 mo after treatment) compared with UC participants. There were no significant differences between the two groups in depression and psychosocial adjustment. |
Alexopoulos et al., 2003 [ ] | PST vs. ST | Clinician referrals and responders to advertisement | 25 | 12 weekly | Doctoral-level clinical psychologists and licensed social workers | Review of 1st, 6th, and 12th sessions of half the subjects | Depression/disability | PST group had greater reduction in depression scores at 12 wk than ST group. PST led to a more rapid improvement in disability at 12 wk than ST. |
Williams et al., 2000 [ ] | Paroxetine vs. PBO vs. PST-PC | Referrals from community, veterans affairs, and primary care clinics | 415 | 6 over 11 wk | Doctoral-level psychologists, social workers, and counselors with master's degree | Therapists certified as competent in PST | Depression | All groups had significant reduction in depression. The paroxetine group had significantly greater reduction in depression than the PBO group, and PST-PC participants had a reduction comparable with that of participants in the other two groups. |
Areán et al., 1993 [ ] | Group PST vs. group RT vs. WLC | Community-dwelling older adults | 75 | 12 weekly group sessions | Advanced graduate students in clinical psychology | Supervision | Depression | Participants in PST had significantly less depression post treatment than participants in RT and those in WLC. |
CHS-PCF, Cardiovascular Health Study–Phenotypic Classification of Frailty; EN, exercise and nutrition program; MDD, major depressive disorder; NR, ; PATH, problem adaptation therapy; PBO, placebo; PST, problem-solving therapy; PST-HC, problem-solving therapy–home care; PST-PC, problem-solving therapy–primary care; RT, reminiscence therapy; ST, supportive therapy; ST-CI, supportive therapy for cognitively impaired older adults; TS, telephone support calls; UC, usual care; UC+E, usual care plus education; WLC, waiting-list condition.
Finally, ongoing clinical trials, not included in the current review, focus on using PST or adaptations of PST to a) reduce depression in low-income, homebound [ 6 ], medically ill older adults [ 7 , 8 ] and opiate abusers [ 9 ] or b) prevent the onset of depressive episodes in high-risk elders [ 10 ].
We searched PubMed (1966–2013), PsycNET (1840–2013), and Cochrane databases, emphasizing studies from the past 5 years. The searches were conducted using the following keywords: “problem solving therapy,” “PST,” “old*,” and “eld*” (the asterisk denotes any combination of the word). In addition, we selected appropriate studies from previously published meta-analyses and reviews. Inclusion criteria of studies were a) an RCT using problem-solving therapy [ 4 , 5 ], b) published in English, and c) with the average participant 60 years old or older. This review does not include interventions that included PST as only one aspect or step of the treatment (e.g., IMPACT, PEARL, or other stepped-cared programs), because PST was given in combination with other depression interventions and the relative effect of PST could not be determined. We identified 734 abstracts and potential articles through our searches, 15 of which were original RCTs that met our criteria; of those, 12 were published in the past 5 years (see Table 1 for the characteristics of the 15 RCTs). Two of 15 were prevention studies in patients with macular degeneration and stroke. The following treatment options are based mainly on results from the analyses of primary outcomes.
Diagnosed major depression
The results are based on four studies of PST [ 11• class I study, 12 – 14 ]. Two multisite studies [ 11• , 12 , 15 ] used a PST adaptation for depressed patients with executive dysfunction (PST-ED) and another study used a PST adaptation (PATH) for depressed patients with advanced cognitive impairment including dementia [ 14 ]. All studies used depression treatment as a control condition (reminiscence therapy [RT] [ 13 ]; supportive therapy [ST] [ 11• class I study, 12 , 14 ].
Despite the strong control condition, PST showed significantly greater reduction in depression post treatment. In one study [ 13 ], the benefits of group PST vs. group RT were maintained at 24 weeks.
Standard procedure
- PST-ED [ 11• class I study, 12 ]: 12 sessions in 12 weeks delivered by doctoral-level clinical psychologists and licensed social workers.
- Home-delivered PATH (problem adaptation therapy) [ 14 ]: 12 sessions in 12 weeks delivered by doctoral-level clinical psychologists and licensed social workers.
- PST [ 13 ]: 12 weekly group sessions delivered by advanced graduate students in clinical psychology.
Special points
- Depressed older adults with executive dysfunction: Participants in PST-ED had a significantly greater reduction in depression than participants in ST over 12 weeks in two multisite studies. Cohen's d ranged from 1.08 [ 12 ] to 0.48 [ 11• class I study]. However, Cohen's d for the 2003 study by Alexopoulos et al. [ 12 ] must be interpreted with caution because of the small sample size.
- Depressed older adults with advanced cognitive impairment: Participants in home-delivered PATH had a significantly greater reduction in depression than participants in home-delivered ST. Cohen's d was 0.77, but it also must be interpreted with caution considering the small sample size (N = 30) [ 14 ].
- Participants in group PST show a greater reduction in depression at 3 months (post treatment) than participants in group RT and those in the wait-list control condition. Estimated Cohen's d between PST vs. RT was 1.08.
Minor depression, dysthymia, or depression symptoms
The results are based on three studies of PST-PC [ 16• class I study] in minor depression or dysthymia and PST-HC [ 17 , 18 ] in depression in home-care patients. Compared with usual care, PST had a greater reduction in depression in home-care patients; however, compared with paroxetine or placebo, PST had a reduction in depression similar to that of paroxetine and placebo in patients with dysthymia and minor depression.
- PST-PC: Six sessions in 11 weeks delivered by doctoral-level psychologists, social workers, and counselors with master's degrees.
- PST-HC: Six sessions in 6 [ 18 ] or 8 weeks [ 17 ] delivered by master's-level social workers.
- PST-PC participants had a reduction in depression comparable to that of participants in the placebo or paroxetine group among patients with dysthymia or minor depression.
- Among home-care patients with subthreshold depression and cardiovascular disease, participants in PST-HC had a significantly greater reduction in depression than usual-care participants.
- Among home-care patients with significant depressive symptoms, participants in PST-HC had a greater reduction in depression and greater improvement in quality of life over the course of 6 months than usual-care participants.
Prevention of depression and apathy
The results are based on two studies of prevention in patients with macular degeneration ([ 19• ] and [ 20 ] used the same sample) and stroke patients ([ 21• ] and [ 22 ] used the same sample). In one study, the outcome was prevention of a major depressive episode [ 19• class I study, 20 ], whereas in the other, the outcome was prevention of a major or minor episode of depression [ 21• class I study] or prevention of onset of apathy [ 22 ].
Stroke patients participating in PST were less likely to develop a major or minor depressive episode than those in the placebo group. This difference became nonsignificant in a more conservative analysis, which assumed that baseline patients who did not continue the study would have developed depression. Among patients with macular degeneration, PST participants had significantly lower 2-month incidence rates of major depression than usual-care participants and were less likely to suffer persistent depression at 6 months. In a recent analysis of the study sample of Robinson et al. [ 21• ] of the subjects who did not exhibit apathy at baseline, escitalopram or PST was significantly more effective in preventing new onset of apathy following stroke compared with placebo [ 22 ].
- Patients with macular degeneration [ 19• class I study, 20 ]: six sessions in 8 weeks delivered by nurses and master's-level counselors.
- Stroke patients [ 21• class I study, 22 ]: six sessions in the first 12 weeks and six reinforcement sessions in the following 9 months.
- Stroke study [ 21• class I study]: placebo participants were 2.2 times more likely than PST participants and 4.5 times more likely than escitalopram participants to develop depression.
- Stroke study [ 22 ] (outcome: onset of apathy): placebo participants were 3.47 times more likely than escitalopram patients and 1.84 times more likely than PST patients to develop apathy.
Functioning, frailty, and quality of life
The results are based on three studies of PST [ 12 , 15 , 14 ]. Two multisite studies [ 12 , 15 ] used PST-ED; the other study used PATH for depressed patients with advanced cognitive impairment including dementia [ 14 ]. All studies used depression treatment as a control condition (ST) [ 12 , 14 , 15 ].
PST participants had significantly greater reduction in disability at 12 weeks than ST participants in all three studies. In one study [ 15 ], the benefits of PST vs. ST were sustained between 12 and 36 weeks.
- PST-ED [ 12 , 15 ]: 12 sessions in 12 weeks delivered by doctoral-level clinical psychologists and licensed social workers.
- Home-delivered PATH (problem adaptation therapy) [ 14 ]: 12 sessions in 12 weeks delivered by a doctoral-level clinical psychologist and licensed social worker.
Exploratory analyses revealed that disability mediated the effects of depression at the end of treatment (12 weeks).
Targeted vision function
The results are based on only one study of patients with age-related macular degeneration [ 23 ]. PST participants did not have greater improvement in vision function than ST participants in the primary outcome measure at 3 months (end of treatment) or 6 months but had greater improvement in the secondary outcome of vision-related quality of life [ 23 ].
- Six sessions in 12 weeks delivered by therapists with a bachelor's or master's degree.
- PST targeting functional problems of vision loss and reducing the difficulty of vision-dependent tasks did not show significant improvement over ST at 3 and 6 months after baseline [ 23 ].
- PST showed greater improvement in the secondary outcome of vision-related quality of life compared with ST.
The results are based on only one study of frail community older adults [ 24 ]. Participants receiving PST did not have significant improvement in any of the frailty measures: weight loss, exhaustion, low activity level, slowness, and weakness.
- Six sessions in 3 months delivered by trained case managers.
Quality of life
The results are based on one study [ 25 ] focusing on a group of outpatients who screened positive for psychological problems by the Chinese version of the Hospital Anxiety and Depression Scale. PST-PC participants had improvement in health-related quality of life comparable with that of placebo participants who watched health education videos.
- PST-PC: three sessions in 6 weeks delivered by primary care doctors.
Although participants in PST-PC had significant improvement in the role-emotional and mental components of the SF-36 Health-Related Quality of Life assessment at week 6, whereas the placebo group did not, a mixed-effects analysis accounting for potential covariates and baseline measures did not show any difference between the two groups in any outcome.
Alternative deliveries
- Older adults who are homebound or live in rural areas may need alternative ways to deliver PST, such as phone, videophone, or Internet.
- Special considerations are required for patients with hearing and vision problems as well as patients with cognitive impairment.
The results are based on three studies of PST delivered through telephone [ 26 ], videophone [ 27 ], or Skype [ 28 ]. The subjects for each study were cancer patients [ 26 ], hospice caregivers [ 27 ], and home-care patients with depression [ 28 ].
- Telephone: varied number of sessions (based on negotiation with the patient) in 3 months delivered by nurse counselors.
- Videophone: three sessions in 20 days.
- Skype: six weekly sessions.
Special Points
- Delivering PST through phone, videophone, and Internet is feasible and acceptable to vulnerable older adults.
- PST counseling delivered over the phone to cancer patients showed greater improvement in certain coping areas than usual care, but there were no significant differences in reduction of depression or improvement in psychosocial adjustment.
- Videophone-delivered PST showed improvement in caregiver quality of life and reduction in anxiety compared with in-person PST.
- PST delivered through Skype demonstrated results comparable with those of in-person PST in homebound older adults, and both PST conditions showed a greater reduction in depression compared with a condition of support calls [ 28 ]. Among patients in the sample, 67% had major depressive disorder, 29% had minor depression, and 4% had dysthymia.
Considerations
Length of treatment.
- Ten of 15 studies had between 6 and 12 PST sessions in 12 weeks.
- The two prevention studies had six sessions in 8 or 12 weeks, and one of them [ 21• , 22 ] had six additional sessions in the following 9 months.
Therapists and treatment fidelity
- Therapists included those with a bachelor's or master's degree in social science, master's-level social workers, nurse counselors, advanced graduate students in clinical psychology, and doctoral-level clinical psychologists.
- Reviews of recorded sessions and notes were performed in 9 of 15 studies.
Race, education, and socioeconomic status
- The majority of participants in most studies were older Caucasian adults with at least 12 years of education. Two studies were conducted in Hong Kong [ 25 ] and in Taiwan [ 24 ]. Future research will focus on racially diverse participants, as well as those with limited education and low socioeconomic status.
Cognitive impairment and dementia
- Older adults with cognitive impairment also may need compensatory strategies, including written session notes, memory devices, environmental adaptations, and caregiver participation, to help them with their cognitive deficits.
Acknowledgments
This paper was supported in part by grants from the National Institute of Mental Health (R01 MH075897, R01 MH076829, and P30 MH085943 [to George S. Alexopoulos] and R01 MH091045 [to Dimitris N. Kiosses]) and an Alzheimer's Association Investigator Initiated Research Grant (to Dimitris N. Kiosses).
George S. Alexopoulos has served as a consultant for Pfizer and Otsuka, has received grants from Forest Laboratories, and has received payment for lectures, including service on speakers bureaus, from AstraZeneca, Avanir Pharmaceuticals, Novartis, and Sunovion.
Compliance with Ethics Guidelines: Conflict of Interest : Dimitris N. Kiosses declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent : This article does not contain any studies with human or animal subjects performed by any of the authors.
Contributor Information
Dimitris N. Kiosses, Weill-Cornell Institute of Geriatric Psychiatry, Weill Cornell Medical College.
George S. Alexopoulos, Weill-Cornell Institute of Geriatric Psychiatry, Weill Cornell Medical College.
Papers of particular interest have been highlighted as:
• Of importance
Problem Solving Therapy: PST in 3 Steps
- December 18, 2021
- No Comments
Problem solving therapy is a psychotherapy that focuses on the cognitive and emotional processes of an individual with the aim to solve their problems. The aim of this blog post is to explore how it works, who can benefit from it and what are its benefits. Problem solving therapy is a cognitive behavioral therapeutic approach that focuses on the present and future rather than the past.
Problem Solving Therapy Steps
What is Problem Solving Therapy?
Problem solving therapy is a cognitive-behavioral technique intended to enhance an individual’s ability to deal with traumatic life events. The premise of problem solving therapy is that people cannot change what has happened, but they can learn to accept it and take control of their life.
Who developed Problem Solving Therapy?
Problem-solving therapy was developed by Jeffrey Young in 1987 as an integration of cognitive psychotherapy, rational emotive behavior therapy, and developmental theories such as Piaget’s theory of moral development.
Regardless of the time, the existence of a problem is often perceived as troubling. The problem is, in the most general sense, “the differences and obstacles between the current situation and the desired situation” (Nezu, Nezu and D ‘Zurilla, 2007).
According to D ‘Zurilla, Nezu, and Maydeu-Olivares’, who suggested the concept of social problem solving based on the fact that a human being is a social entity, the problem is “when a person needs to react to adapt in case of any life situation or task that needs to be accomplished. It occurs when there is no obvious or obviously effective response depending on the presence of obstacles. In fact, the problem arises when a person makes a “mistake in showing the effective and appropriate response” or “a difference between what he is currently in and what he wants to be”.
The existence of a problematic situation inevitably requires an effort for a solution. Therefore, the problem situation requires coping, dealing with obstacles, and more effort and especially change. In other words, it is necessary to act and change in order to reach the desired situation from the current situation. Changing can also be perceived as a difficult and disturbing process. At this point, people’s problem-solving styles may differ, whether effective or ineffective.
D’Zurilla and Nezu (1990) define social problem solving as the cognitive, affective, and behavioral process that the individual attempts and produces to find an effective way to cope with problem situations in daily life.
The main purpose of problem solving therapy is to teach people how to approach the problems they face and the strategies they will follow to solve the problems. From this point of view, problem solving therapy aims to both treat mental problems caused by the failure of the problems and prevent the occurrence of psychological problems.
Problem-solving therapy recognizes that any problems we experience are part of our lives. We can be sick at any moment, lose someone we love, be abandoned by our beloved, be fired from our job, be humiliated by others, suffer injustice. So the dream of a smooth world is unrealistic. The important thing is how we deal with them rather than the existence of problems.
The main starting point of problem solving therapy is that the problem solving skills of people who have mental problems are not sufficient and effective. Problem solving therapy, which is a cognitive-behavioral therapy model, focuses on the thoughts and behaviors of people. This method acknowledges that functional changes in thoughts and behaviors will be effective in the treatment of psychological problems.
Problem solving therapy is a cognitive-behavioral method. The importance of this is that the effectiveness of therapy has been proven by experimental studies. Scientific studies have shown that the inadequacies of people in their problem solving abilities are effective both in forming and maintaining psychopathologies. Therefore, problem solving therapy can be used both to overcome psychological problems caused by the problems experienced and to effectively deal with the problems.
Why Do We Need Problem Solving Therapy?
Some people may find it difficult to solve problems on their own, which can lead to frustration, anxiety, and even depression. Problem-solving therapy is a type of talk therapy that can help people learn how to solve problems in a healthy way.
The therapist will work with the patient to identify and understand the problem, brainstorm possible solutions, select the best solution, and put the plan into action. This type of therapy can be helpful for people who have difficulty coping with stress or who are dealing with a major life change.
Working with a therapist is beneficial because they will have access to tools that allow them to find the root causes of the problem.
There is also often a misconnection in early childhood that leads people to seek this type of therapy which, again means they’re less likely to try and self-solve their own issues.
Effectiveness of Problem Solving Theory
Problem-solving therapy was created to assist customers to solve problems and improve their lives. It was later modified to focus on treating clinical depression specifically. Today, the majority of the research on problem-solving therapy is concerned with how effectively it can help people get over sadness.
Problem-solving therapy has been shown to help depression in:
- Elder people
- People coping with severe illnesses like cancer
Problem-solving therapy has also been found to be beneficial as a brief therapy for depression, with benefits seen after just six to eight sessions with a therapist or another healthcare professional. This may make it an appealing alternative for those who are unable to commit to a longer depression treatment.
Last Updated on December 10, 2022 by Lucas Berg
Your email address will not be published. Required fields are marked *
Table of Contents
Related post, what is pmdd and how does it affect mental health, the myth of napoleon complex in women and 9 most successful short women celebrities, family counseling services: everything you should know, privacy overview.
An official website of the United States government
The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
- Publications
- Account settings
- My Bibliography
- Collections
- Citation manager
Save citation to file
Email citation, add to collections.
- Create a new collection
- Add to an existing collection
Add to My Bibliography
Your saved search, create a file for external citation management software, your rss feed.
- Search in PubMed
- Search in NLM Catalog
- Add to Search
Problem solving therapy for the depression-executive dysfunction syndrome of late life
Affiliation.
- 1 Department of Psychiatry, Weill Cornell Medical College, White Plains, NY 10605, USA. [email protected]
- PMID: 18213605
- DOI: 10.1002/gps.1988
Background: The 'depression executive dysfunction syndrome' afflicts a considerable number of depressed elderly patients and may be resistant to conventional pharmacotherapy. Non-pharmacological approaches addressing their behavioral deficits may reduce disability and experienced stress and improve depression.
Methods: This paper focuses on problem solving therapy (PST) because it targets concrete problems that can be understood by patients with executive dysfunction and trains patients to address them using an easy to comprehend structured approach.
Results: We suggest that PST is a suitable treatment for patients with the depression-executive dysfunction syndrome because it has been found effective in uncomplicated geriatric major depression and in other psychiatric disorders accompanied by severe executive dysfunction. Furthermore, PST can address specific clinical features of depressed patients with executive dysfunction, especially when modified to address difficulties with affect regulation, initiation and perseveration.
Conclusions: A preliminary study suggests that appropriately modified PST improves problem solving skills, depression and disability in elderly patients with the depression-executive dysfunction syndrome of late life. If these findings are confirmed, PST may become a therapeutic option for a large group of depressed elderly patients likely to be drug resistant.
PubMed Disclaimer
Similar articles
- [Depression and frontal dysfunction: risks for the elderly?]. Thomas P, Hazif Thomas C, Billon R, Peix R, Faugeron P, Clément JP. Thomas P, et al. Encephale. 2009 Sep;35(4):361-9. doi: 10.1016/j.encep.2008.03.012. Epub 2008 Oct 1. Encephale. 2009. PMID: 19748373 French.
- [Impairment of executive function in elderly patients with major unipolar depression: influence of psychomotor retardation]. Baudic S, Benisty S, Dalla Barba G, Traykov L. Baudic S, et al. Psychol Neuropsychiatr Vieil. 2007 Mar;5(1):65-71. Psychol Neuropsychiatr Vieil. 2007. PMID: 17412666 French.
- Attention and executive functions in remitted major depression patients. Paelecke-Habermann Y, Pohl J, Leplow B. Paelecke-Habermann Y, et al. J Affect Disord. 2005 Dec;89(1-3):125-35. doi: 10.1016/j.jad.2005.09.006. Epub 2005 Dec 1. J Affect Disord. 2005. PMID: 16324752
- Executive dysfunction in major depressive disorder. DeBattista C. DeBattista C. Expert Rev Neurother. 2005 Jan;5(1):79-83. doi: 10.1586/14737175.5.1.79. Expert Rev Neurother. 2005. PMID: 15853477 Review.
- [Executive functioning in unipolar depression: a review]. Fossati P, Ergis AM, Allilaire JF. Fossati P, et al. Encephale. 2002 Mar-Apr;28(2):97-107. Encephale. 2002. PMID: 11972136 Review. French.
- Cognitive outcomes are differentially associated with depression severity trajectories during psychotherapy treatment for late life major depressive disorder. Kassel MT, Rhodes E, Insel PS, Woodworth K, Garrison-Diehn C, Satre DD, Nelson JC, Tosun D, Mackin RS. Kassel MT, et al. Int J Geriatr Psychiatry. 2022 Aug;37(8):10.1002/gps.5779. doi: 10.1002/gps.5779. Int J Geriatr Psychiatry. 2022. PMID: 35822633 Free PMC article.
- Late Life Depression: The Essentials and the Essential Distinctions. Husain-Krautter S, Ellison JM. Husain-Krautter S, et al. Focus (Am Psychiatr Publ). 2021 Jul;19(3):282-293. doi: 10.1176/appi.focus.20210006. Epub 2021 Jul 9. Focus (Am Psychiatr Publ). 2021. PMID: 34690594 Free PMC article.
- Problem-Solving Therapy Effects on Suicidal Ideation: The Role of Reduction in Functional Disability. Szanto K, Gujral S. Szanto K, et al. Am J Geriatr Psychiatry. 2021 Jun;29(6):562-564. doi: 10.1016/j.jagp.2020.10.017. Epub 2020 Nov 4. Am J Geriatr Psychiatry. 2021. PMID: 33183949 Free PMC article. No abstract available.
- Interpersonal Psychotherapy for Late-life Depression and its Potential Application in China. Xu H, Koszycki D. Xu H, et al. Neuropsychiatr Dis Treat. 2020 Aug 7;16:1919-1928. doi: 10.2147/NDT.S248027. eCollection 2020. Neuropsychiatr Dis Treat. 2020. PMID: 32821108 Free PMC article. Review.
- Advances in Pharmacotherapy of Late-Life Depression. Beyer JL, Johnson KG. Beyer JL, et al. Curr Psychiatry Rep. 2018 Apr 7;20(5):34. doi: 10.1007/s11920-018-0899-6. Curr Psychiatry Rep. 2018. PMID: 29627920 Review.
Publication types
Grants and funding
- K23 MH 69784/MH/NIMH NIH HHS/United States
- K24 MH 074717/MH/NIMH NIH HHS/United States
- MH 51956/MH/NIMH NIH HHS/United States
- P30 MH 68638/MH/NIMH NIH HHS/United States
- R25 MH 074500/MH/NIMH NIH HHS/United States
- UD2 SM 52643/SM/CMHS SAMHSA HHS/United States
LinkOut - more resources
Full text sources.
- Ovid Technologies, Inc.
- Genetic Alliance
NCBI Literature Resources
MeSH PMC Bookshelf Disclaimer
The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.
COMMENTS
Problem-solving therapy (PST) is an intervention with cognitive and behavioral influences used to assist individuals in managing life problems. Therapists help clients learn effective skills to address their issues directly and make positive changes. PST is used in various settings to address mental health concerns such as depression, anxiety, and more.
Problem-solving therapy is a brief intervention that provides people with the tools they need to identify and solve problems that arise from big and small life stressors. It aims to improve your overall quality of life and reduce the negative impact of psychological and physical illness. Problem-solving therapy can be used to treat depression ...
Problem-Solving Treatment (PST) is a brief form of evidence-based psychotherapy. PST has been used since the 1970's as a standalone intervention. It has been studied extensively in a wide range of settings and with a variety of providers and patient populations, and there are over 80 peer-reviewed articles on its use. While there are many ...
Updated: July 1, 2021. Problem-Solving Treatment (PST) is a brief form of evidence-based treatment that was originally developed in Great Britain for use by medical professionals in primary care. It is also known as Problem-Solving Treatment - Primary Care (PST-PC). PST has been studied extensively in a wide range of settings and with a ...
Problem-solving therapy (PST) takes a results-oriented approach to managing issues. PST is rooted in cognitive behavioral therapy (CBT) and can also be referred to as problem-solving brief therapy (PSBT). It's growing in popularity thanks to evidence showing it can effectively treat a variety of health and mental health problems, such as ...
The overarching goal of problem-solving therapy (PST) is to enhance the individual's ability to cope with stressful life experiences and to foster general behavioral competence. The major assumption underlying this approach, which emanates from a cognitive-behavioral tradition, is that much of what is viewed as "psychopathology" can be ...
"Problem-solving therapy (PST) is a psychosocial intervention, generally considered to be under a cognitive-behavioral umbrella" (Nezu, Nezu, & D'Zurilla, 2013, p. ix). It aims to encourage the client to cope better with day-to-day problems and traumatic events and reduce their impact on mental and physical wellbeing.
Problem-Solving Therapy (PST) is a cognitive-behavioral intervention that helps individuals manage the challenges and difficulties of life by improving their problem-solving skills. PST focuses on teaching clients to identify, prioritize, and effectively address problems in a systematic way. This approach encourages a proactive stance towards ...
Problem-solving therapy (PST) is a brief evidence- and strength-based psychotherapy that has received increasing support for its effectiveness in managing depression and anxiety among primary care patients. Methods: We conducted a systematic review and meta-analysis of clinical trials examining PST for patients with depression and/or anxiety in ...
Problem solving therapy is a widely-acknowledged tool used by therapists and general medical practitioners alike to help clients find proactive and reasonable ways to deal with the stressful events that occur in their lives. Overall, PST can help people find meaningful, creative, and adjustable ways of reaching their problem-resolution goals ...
Problem solving therapy (PST) is one of the focused psychological strategies supported by Medicare for use by appropriately trained general practitioners. Problem solving therapy has been described as pragmatic, effective and easy to learn. It is an approach that makes sense to patients and professionals, does not require years of training and…
Problem-Solving Therapy (PST) is a brief, psychosocial treatment for patients experiencing depression and distress related to inefficient problem-solving skills. The PST model instructs patients on problem identification, efficient problem solving, and managing associated depressive symptoms. PST was originally developed in
Recommendation Resources. Problem-Solving Therapy (PST) for Suicide Prevention is a brief form of evidence-based treatment that teaches and empowers patients to solve the here-and-now problems contributing to suicidal ideation, self-directed violence and hopelessness. It has been shown to help increase self-efficacy and reduce risk of self-harm ...
This book chapter provides a practical overview of Problem-Solving Therapy (PST) for late-life depression, an evidence-based psychotherapy for depression with particularly robust evidence for use with older adults. The theoretical framework of PST and a typical course of treatment is presented, illustrated by a case of an older depressed ...
Essence of therapy: Contemporary Problem-Solving Therapy, or PST, is a transdiagnostic intervention, generally considered to be under a cognitive-behavioral umbrella, that increases adaptive adjustment to life problems and stress by training individuals in several affective, cognitive, and behavioral tools. The training is aimed at several ...
What is Problem-Solving Therapy? Problem-Solving Therapy (PST) is an evidenced-based intervention to facilitate behavioral changes through a variety of skill training. PST identifies strategies to support people to cope with difficulties in life and take the initiative to solve everyday problems.
Problem-Solving Therapy (PST) PST is a therapy for Veterans who are experiencing depression or suicidal thoughts. PST can help you recover from the effects of experiencing difficult situations and learn skills for coping with challenging life circumstances and chronic daily stressors.
This review assessed the efficacy of problem-solving therapy (PST) in helping individuals to overcome any type of health problem. The authors concluded that there is strong evidence for the effectiveness of PST. The conclusion was derived from a meta-analysis of clinically and statistically variable data and there were a number of methodological concerns, therefore it may not be reliable.
Background: Problem solving therapy (PST) is one of the focused psychological strategies supported by Medicare for use by appropriately trained general practitioners. Objective: This article reviews the evidence base for PST and its use in the general practice setting. Discussion: Problem solving therapy involves patients learning or reactivating problem solving skills.
Problem-solving therapy (PST) is a psychotherapy that has been used widely in psychiatry. Meta-analyses have highlighted the use of PST in a variety of conditions, including depressive disorders, conduct disorders, obesity, and substance abuse, across different populations ...
Eye movement desensitization and reprocessing (EMDR) practice guide. Positive psychology practice guide. Problem-solving therapy (PST) practice guide. This brief guide provides information on problem-solving therapy, including the underlying skills, processes and techniques, and the applications and efficacy of this treatment approach.
Problem-solving therapy was developed by Jeffrey Young in 1987 as an integration of cognitive psychotherapy, rational emotive behavior therapy, and developmental theories such as Piaget's theory of moral development. Regardless of the time, the existence of a problem is often perceived as troubling. The problem is, in the most general sense ...
A preliminary study suggests that appropriately modified PST improves problem solving skills, depression and disability in elderly patients with the depression-executive dysfunction syndrome of late life. If these findings are confirmed, PST may become a therapeutic option for a large group of depre …
As is typical of an office-based role, employees must be able, with or without an accommodation to: use a computer; engage in communications via phone, video, and electronic messaging; engage in problem solving and non-linear thought, analysis, and dialogue; collaborate with others; maintain general availability during standard business hours.